Biologically targeted cancer therapy and marginal benefits: are we making too much of too little or are we achieving too little by giving too much? von Fojo, Tito, Parkinson, David R

Volltext

Considerations in the development of circulating tumor cell technology for clinical use von Parkinson, David R, Dracopoli, Nicholas, Petty, Brenda Gumbs, Compton, Carolyn, Cristofanilli, Massimo, Deisseroth, Albert, Hayes, Daniel F, Kapke, Gordon, Kumar, Prasanna, Lee, Jerry Sh, Liu, Minetta C, McCormack, Robert, Mikulski, Stanislaw, Nagahara, Larry, Pantel, Klaus, Pearson-White, Sonia, Punnoose, Elizabeth A, Roadcap, Lori T, Schade, Andrew E, Scher, Howard I, Sigman, Caroline C, Kelloff, Gary J

Volltext

Making Personalized Cancer Medicine a Reality: Challenges and Opportunities in the Development of Biomarkers and Companion Diagnostics von PARKINSON, David R, JOHNSON, Bruce E, SLEDGE, George W

Volltext

Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development von PARK, John W, KERBEL, Robert S, KELLOFF, Gary J, BARRETT, J. Carl, CHABNER, Bruce A, PARKINSON, David R, PECK, Jonathan, RUDDON, Raymond W, SIGMAN, Caroline C, SLAMON, Dennis J

Volltext

Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer von Parkinson, David R, McCormack, Robert T, Keating, Susan M, Gutman, Steven I, Hamilton, Stanley R, Mansfield, Elizabeth A, Piper, Margaret A, Deverka, Patricia, Frueh, Felix W, Jessup, J Milburn, McShane, Lisa M, Tunis, Sean R, Sigman, Caroline C, Kelloff, Gary J

Volltext

Leveling the Playing Field: Bringing Development of Biomarkers and Molecular Diagnostics up to the Standards for Drug Development von POSTE, George, CARBONE, David P, PARKINSON, David R, VERWEIJ, Jaap, HEWITT, Stephen M, MILBURN JESSUP, J

Volltext

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19 von Ascierto, Paolo Antonio, Fox, Bernard A, Urba, Walter J, Anderson, Ana Carrizosa, Atkins, Michael B, Borden, Ernest C, Brahmer, Julie R, Butterfield, Lisa H, Cesano, Alessandra, Chen, Daniel S, de Gruijl, Tanja D, Dillman, Robert O, Drake, Charles G, Emens, Leisha A, Gajewski, Thomas F, Gulley, James L, Stephen Hodi Jr, F, Hwu, Patrick, Kaufman, David, Kaufman, Howard L, Lotze, Michael T, McNeel, Douglas G, Margolin, Kim A, Marincola, Francesco M, Mastrangelo, Michael J, Maus, Marcela V, Parkinson, David R, Romero, Pedro J, Sondel, Paul M, Spranger, Stefani, Sznol, Mario, Weiner, George J, Wigginton, Jon M, Weber, Jeffrey S

Volltext

Soft tissue sarcomas of adults: State of the translational science von BORDEN, Ernest C, BAKER, Lurence H, O'SULLIVAN, Brian, PARKINSON, David R, PISTERS, Peter W. T, SAXMAN, Scott, SINGER, Samuel, SUNDARAM, Murali, VAN OOSTEROM, Allan T, VERWEIJ, Jaap, WAALEN, Jill, WEISS, Sharon W, BELL, Robert S, BRENNAN, Murray F, BRAMWELL, Vivien, DEMETRI, George D, EISENBERG, Burton L, FLETCHER, Christopher D. M, FLETCHER, Jonathan A, LADANYI, Marc, MELTZER, Paul

Volltext

Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancer von RUSTIN, Gordon J. S, BAST, Robert C, KELLOFF, Gary J, BARRETT, J. Carl, CARTER, Stephen K, NISEN, Perry D, SIGMAN, Caroline C, PARKINSON, David R, RUDDON, Raymond W

Volltext

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE von Alexander, Brian M, Ba, Sujuan, Berger, Mitchel S, Berry, Donald A, Cavenee, Webster K, Chang, Susan M, Cloughesy, Timothy F, Jiang, Tao, Khasraw, Mustafa, Li, Wenbin, Mittman, Robert, Poste, George H, Wen, Patrick Y, Yung, W K Alfred, Barker, Anna D

Volltext

Reanalysis of cancer drugs: Old drugs, new tricks von VANDE WOUDE, George F, KELLOFF, Gary J, SLICHENMYER, William J, RUDDON, Raymond W, KOO, Han-Mo, SIGMAN, Caroline C, BARRETT, J. Carl, DAY, Robert W, DICKER, Adam P, KERBEL, Robert S, PARKINSON, David R

Volltext

Measuring the effective complexity of cosmological models von Kunz, Martin, Trotta, Roberto, Parkinson, David R.

Volltext

Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells von Atkins, Michael B, Mier, James W, Parkinson, David R, Gould, Jody A, Berkman, Eugene M, Kaplan, Michael M

Volltext

Biologically Targeted Cancer Therapy and Marginal Benefits: Are We Making Too Much of Too Little or Are We Achieving Too Little by Giving Too Much? : Improving Outcomes in Oncology von FOJO, Tito, PARKINSON, David R

Volltext

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy von FYFE, G, FISHER, R. I, ROSENBERG, S. A, SZNOL, M, PARKINSON, D. R, LOUIE, A. C

Volltext

Unique allelic restriction fragments of the human Ha- ras locus in leukocyte and tumour DNAs of cancer patients von Krontiris, Theodore G, DiMartino, Nancy A, Colb, Mark, Parkinson, David R

Volltext

Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2 von Rosenberg, Steven A., Yannelli, John R., Yang, James C., Topalian, Suzanne L., Schwartzentruber, Douglas J., Weber, Jeffrey S., Parkinson, David R., Seipp, Claudia A., Einhorn, Jan H., White, Donald E.

Volltext

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy von MARINCOLA, F. M, VENZON, D, WHITE, D, RUBIN, J. T, LOTZE, M. T, SIMONIS, T. B, BALKISSOON, J, ROSENBERG, S. A, PARKINSON, D. R

Volltext

Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer : PRECISION MEDICINE von PARKINSON, David R, McCORMACK, Robert T, McSHANE, Lisa M, TUNIS, Sean R, SIGMAN, Caroline C, KELLOFF, Gary J, KEATING, Susan M, GUTMAN, Steven I, HAMILTON, Stanley R, MANSFIELD, Elizabeth A, PIPER, Margaret A, DEVERKA, Patricia, FRUEH, Felix W, JESSUP, J. Milburn

Volltext

Retinoids in cancer therapy von SMITH, M. A, PARKINSON, D. R, CHESON, B. D, FRIEDMAN, M. A

Volltext